CHAPEL HILL, N.C., March 23, 2018 /PRNewswire/ -- Biopharmaceutical and medical device companies allocate a significant amountof resources to ensure their products meet quality standards at every stage of the product lifecycle.
Inherent in this challenging endeavor is the balancing act between managing costs and product quality while adding value for patients and healthcare
Best Practices, LLC undertook benchmarking research to probe how quality organizations can move beyond simply ensuring product safety and compliance and deliver value. "Benchmarking Quality in the Biopharmaceutical & Medical Device Sectors," is a wide-ranging research study that probes how both global and local quality teams can deliver on all these fronts.
Some of the issues addressed in this new report include:
The full 121-page report contains more than 600 metrics, providing quality leaders with critical benchmarks that will allow them to compare their operations with those of leading organizations.
Best Practices, LLC engaged 23 quality leaders from 23 pharma and medical device companies through a benchmarking survey. Qualitative data was collected via deep-dive interviews with quality leadership teams. This report includes segmented data for pharma and medical device companies.
To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1489.htm.
For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLCBest Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
View original content:http://www.prnewswire.com/news-releases/study-examines-challenge-of-integrating-value-into-quality-function-in-global-pharmaceutical-and-medical-device-companies-300618435.html
SOURCE Best Practices, LLC
Subscribe to our Free Newsletters!
Bubonic plague is an infectious disease caused by the bacteria Yersinia pestis present in rodents ...
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...
Abruptio placenta is a serious but rare complication of pregnancy where a separation of placenta ...View All